Privia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024. In the quarter to June 2026, revenue grew 21.4%, EPS grew 250.0% and free cash flow fell 86.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
Follow PRVA
Privia Health Group, Inc. (PRVA) Piotroski F-score
Privia Health Group, Inc.'s Piotroski F-score for fiscal 2025 is 6 out of 9: 6 of nine tests of profitability, leverage and efficiency passed, unchanged from fiscal 2024.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2025 | 6 | 0.00 |
| FY2024 | 6 | 0.00 |
| FY2023 | 6 | 1.00 |
| FY2022 | 5 | — |
How fiscal 2025’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | 1.83% | 1.35% | Pass | 1 |
| Positive operating cash flow | 163.40m | 109.28m | Pass | 1 |
| Rising return on assets | 1.83% | 1.35% | Pass | 1 |
| Cash flow above net income | 140.49m | 94.90m | Pass | 1 |
| Falling long-term leverage | 0.00 | 0.00 | Pass | 1 |
| Rising current ratio | 1.60 | 1.86 | Fail | 0 |
| No new shares issued | 122,177,000 | 119,403,000 | Fail | 0 |
| Rising gross margin | 9.87% | 10.19% | Fail | 0 |
| Rising asset turnover | 1.69 | 1.63 | Pass | 1 |
| Piotroski F-score | Mixed | 6 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| OMCL Omnicell, Inc. compare | 7 |
| CERT Certara, Inc. compare | 6 |
| WAY Waystar Holding Corp. compare | 6 |
| PRVA Privia Health Group, Inc. | 6 |
| GDRX GoodRx Holdings, Inc. compare | 6 |
| SDGR Schrodinger, Inc. compare | 5 |
| HTFL Heartflow, Inc. compare | 5 |
| DOCS Doximity, Inc. compare | 5 |
| OMDA Omada Health, Inc. compare | — |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover